Review of cancer genomics data sets available via the cBioPortal for Cancer Genomics [51] reveals amplification of HSD11B1 expression in 8–10% of breast and hepatobiliary cancer studies, while around 8% of cutaneous melanomas show either mutation (4%) or amplification (4%) of the gene. Here, HSD11B1 is linked to cutaneous melanoma.